Paradigm BioCapital Advisors LP - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-18
4:30 pm
Purchase
2025-11-1113GVor Biopharma Inc.
VOR
Paradigm BioCapital Advisors LP1,750,000
8.600%
1,750,000increase
(New Position)
Filing
History
2025-11-14
4:34 pm
Sale
2025-09-3013GCogent Biosciences, Inc.
COGT
Paradigm BioCapital Advisors LP3,156,398
2.300%
-7,196,051decrease
(-69.51%)
Filing
History
2025-11-14
4:34 pm
Sale
2025-09-3013GAgios Pharmaceuticals, Inc.
AGIO
Paradigm BioCapital Advisors LP2,873,555
4.900%
-154,422decrease
(-5.10%)
Filing
History
2025-11-14
4:34 pm
Sale
2025-09-3013GCidara Therapeutics, Inc.
CDTX
Paradigm BioCapital Advisors LP961,164
3.300%
-167,449decrease
(-14.84%)
Filing
History
2025-11-14
4:32 pm
Sale
2025-09-3013GLENZ Therapeutics, Inc.
LENZ
Paradigm BioCapital Advisors LP1,073,461
3.800%
-346,371decrease
(-24.40%)
Filing
History
2025-11-14
4:32 pm
Purchase
2025-09-3013GMerus N.V.
MRUS
Paradigm BioCapital Advisors LP4,673,770
6.200%
1,119,711increase
(+31.51%)
Filing
History
2025-11-14
4:31 pm
Purchase
2025-09-3013GUroGen Pharma Ltd.
URGN
Paradigm BioCapital Advisors LP4,216,084
9.000%
1,884,018increase
(+80.79%)
Filing
History
2025-11-14
4:31 pm
Sale
2025-09-3013GY-mAbs Therapeutics, Inc.
YMAB
Paradigm BioCapital Advisors LP0
0.000%
-4,086,346decrease
(Position Closed)
Filing
History
2025-08-28
4:31 pm
Purchase
2025-08-2113GAgios Pharmaceuticals, Inc.
AGIO
Paradigm BioCapital Advisors LP3,027,977
5.200%
3,027,977increase
(New Position)
Filing
History
2025-08-14
4:31 pm
Purchase
2025-06-3013GCogent Biosciences, Inc.
COGT
Paradigm BioCapital Advisors LP10,352,449
9.100%
1,388,794increase
(+15.49%)
Filing
History
2025-08-14
4:31 pm
Sale
2025-06-3013GJanux Therapeutics, Inc.
JANX
Paradigm BioCapital Advisors LP2,920,258
4.900%
-595,728decrease
(-16.94%)
Filing
History
2025-08-12
4:30 pm
Purchase
2025-08-0513GUroGen Pharma Ltd.
URGN
Paradigm BioCapital Advisors LP2,332,066
5.000%
2,332,066increase
(New Position)
Filing
History
2025-07-30
4:14 pm
Purchase
2025-07-2313GCidara Therapeutics, Inc.
CDTX
Paradigm BioCapital Advisors LP1,128,613
5.600%
1,128,613increase
(New Position)
Filing
History
2025-05-15
4:40 pm
Sale
2025-03-3113GDisc Medicine, Inc.
IRON
Paradigm BioCapital Advisors LP1,210,971
3.500%
-286,749decrease
(-19.15%)
Filing
History
2025-05-15
4:39 pm
Sale
2025-03-3113GPliant Therapeutics, Inc.
PLRX
Paradigm BioCapital Advisors LP0
0.000%
-3,059,411decrease
(Position Closed)
Filing
History
2025-05-15
4:39 pm
Purchase
2025-03-3113GCogent Biosciences, Inc.
COGT
Paradigm BioCapital Advisors LP8,963,655
7.900%
3,403,731increase
(+61.22%)
Filing
History
2025-04-10
4:19 pm
Purchase
2025-04-0313GMerus N.V.
MRUS
Paradigm BioCapital Advisors LP3,554,059
5.100%
3,554,059increase
(New Position)
Filing
History
2025-03-27
4:21 pm
Purchase
2025-03-2013GLENZ Therapeutics, Inc.
LENZ
Paradigm BioCapital Advisors LP1,419,832
5.200%
1,419,832increase
(New Position)
Filing
History
2025-02-14
4:45 pm
Purchase
2024-12-3113GOlema Pharmaceuticals, Inc.
OLMA
Paradigm BioCapital Advisors LP7,429,355
9.990%
1,925,755increase
(+34.99%)
Filing
History
2025-02-14
4:42 pm
Sale
2024-12-3113GKura Oncology, Inc.
KURA
Paradigm BioCapital Advisors LP0
0.000%
-4,331,321decrease
(Position Closed)
Filing
History
Goto 0, 1, 2, 3, Next